Q

Qingdao Baheal Medical Inc
SZSE:301015

Watchlist Manager
Qingdao Baheal Medical Inc
SZSE:301015
Watchlist
Price: 27.18 CNY -1.52%
Market Cap: 14.3B CNY
Have any thoughts about
Qingdao Baheal Medical Inc?
Write Note

Qingdao Baheal Medical Inc
Pre-Tax Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Qingdao Baheal Medical Inc
Pre-Tax Income Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Pre-Tax Income CAGR 3Y CAGR 5Y CAGR 10Y
Q
Qingdao Baheal Medical Inc
SZSE:301015
Pre-Tax Income
ÂĄ873.6m
CAGR 3-Years
33%
CAGR 5-Years
21%
CAGR 10-Years
N/A
Sinopharm Group Co Ltd
HKEX:1099
Pre-Tax Income
ÂĄ18.2B
CAGR 3-Years
2%
CAGR 5-Years
6%
CAGR 10-Years
13%
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
Pre-Tax Income
ÂĄ7.2B
CAGR 3-Years
-5%
CAGR 5-Years
5%
CAGR 10-Years
7%
Jointown Pharmaceutical Group Co Ltd
SSE:600998
Pre-Tax Income
ÂĄ2.9B
CAGR 3-Years
-13%
CAGR 5-Years
6%
CAGR 10-Years
15%
C
China National Medicines Corp Ltd
SSE:600511
Pre-Tax Income
ÂĄ2.9B
CAGR 3-Years
8%
CAGR 5-Years
5%
CAGR 10-Years
17%
Huadong Medicine Co Ltd
SZSE:000963
Pre-Tax Income
ÂĄ3.9B
CAGR 3-Years
12%
CAGR 5-Years
4%
CAGR 10-Years
13%
No Stocks Found

Qingdao Baheal Medical Inc
Glance View

Market Cap
14.3B CNY
Industry
Health Care

Qingdao Baheal Medical, Inc. engages in the provision of marketing services for pharmaceutical product manufacturers. The company is headquartered in Qingdao, Shandong and currently employs 2,396 full-time employees. The company went IPO on 2021-06-30. The firm provides brand operation, wholesale distribution and retail services for pharmaceutical products. Its brand operation services include consumer education, product academic promotion, marketing planning, business contacts, product distribution, flow tracking and supply chain management services. The firm's wholesale distribution business mainly centers on Qingdao and Beijing, and radiates second-level and above hospitals, community clinics and pharmacies in surrounding cities. Its wholesale distribution products include medicines, Chinese herbal medicine pieces, medical equipment, diagnostic reagents, medical consumables, among others. The firm mainly conducts its business within domestic market.

Intrinsic Value
45.79 CNY
Undervaluation 41%
Intrinsic Value
Price
Q

See Also

What is Qingdao Baheal Medical Inc's Pre-Tax Income?
Pre-Tax Income
873.6m CNY

Based on the financial report for Dec 31, 2023, Qingdao Baheal Medical Inc's Pre-Tax Income amounts to 873.6m CNY.

What is Qingdao Baheal Medical Inc's Pre-Tax Income growth rate?
Pre-Tax Income CAGR 5Y
21%

Over the last year, the Pre-Tax Income growth was 31%. The average annual Pre-Tax Income growth rates for Qingdao Baheal Medical Inc have been 33% over the past three years , 21% over the past five years .

Back to Top